ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,033,426 | +0.0% | 500,059 | -7.2% | 0.10% | +3.2% |
| Q2 2023 | $29,021,260 | +38.1% | 539,128 | +1.9% | 0.09% | +27.4% |
| Q1 2023 | $21,017,044 | -1.0% | 529,130 | +0.3% | 0.07% | -9.9% |
| Q4 2022 | $21,219,917 | +20.6% | 527,465 | -3.6% | 0.08% | +15.7% |
| Q3 2022 | $17,593,000 | +6.4% | 547,389 | -1.7% | 0.07% | +14.8% |
| Q2 2022 | $16,528,000 | +2.9% | 557,054 | -2.5% | 0.06% | +27.1% |
| Q1 2022 | $16,056,000 | -22.8% | 571,180 | +26.5% | 0.05% | -14.3% |
| Q4 2021 | $20,803,000 | +69.4% | 451,444 | +20.7% | 0.06% | +60.0% |
| Q3 2021 | $12,278,000 | +47123.1% | 374,106 | +49450.5% | 0.04% | – |
| Q2 2021 | $26,000 | – | 755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |